Cargando…
LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway
The involvement of long non‐coding RNAs (lncRNAs), differentially expressed genes and signals in prostate cancer (PCa) continues to be a subject of investigation. This study determined effects of LOC100996425 on human PCa by targeting hepatocyte nuclear factor 4A (HNF4A) via the AMPK/mTOR pathway. P...
Autores principales: | Wang, Xiuyan, Song, Bin, Zang, Mingcui, Ji, He, Yang, He, Jiang, Shuang, Yang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419185/ https://www.ncbi.nlm.nih.gov/pubmed/34309216 http://dx.doi.org/10.1111/jcmm.16657 |
Ejemplares similares
-
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer
por: Audet-Walsh, Étienne, et al.
Publicado: (2017) -
AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia
por: Chun, Yoomi, et al.
Publicado: (2021) -
Dehydroepiandrosterone alleviates oleic acid-induced lipid metabolism disorders through activation of AMPK-mTOR signal pathway in primary chicken hepatocytes
por: Yao, Yao, et al.
Publicado: (2022) -
Protocol for the assessment of mTOR activity in mouse primary hepatocytes
por: Plata-Gómez, Ana Belén, et al.
Publicado: (2021) -
Alpha-ketoglutarate extends Drosophila lifespan by inhibiting mTOR and activating AMPK
por: Su, Yuan, et al.
Publicado: (2019)